Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 5, 2013, Pages 606-612

  Ceylan, Bahadir ^a   Fincanci, Muzaffer ^b   Yardimci, Cem ^b   Eren, Gülhan ^b   Tözalgan, Ümit ^b   Müderrisoǧlu, Cüneyt ^c   Paşaoǧlu, Esra ^d  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b Clinic of Infectious Diseases and Clinical Microbiology   (Turkey)

^c Division of Internal Diseases   (Turkey)

^d ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

blood platelets; hepatitis B virus; liver fibrosis

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; SERUM GLOBULIN; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CASE CONTROL STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDEPENDENT VARIABLE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL SIZE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84876412171     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835d08da     Document Type: Article

References (40)

1. Mutimer DJ, Lok A. Management of HBV- and HCV-induced end stage liver disease. Gut 2012; 61:59-67.
2. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007; 45:297-306. (Pubitemid 46374586)
3. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43:1317-1325. (Pubitemid 43980111)
4. Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, et al. Validation of the fibrotest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003; 49:450-454. (Pubitemid 36250205)
5. Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51:1867-1873. (Pubitemid 41368177)
6. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526. (Pubitemid 36919874)
7. Turhan O, Coban E, Inan D, Yalcin AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit 2010; 16:202-205.
8. Ekiz F, Yuksel O, Kocak E, Yilmaz B, Altinbas A, Coban S, et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2011; 25:162-165.
9. Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E, et al. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clin Res Hepatol Gastroenterol 2012 [Epub ahead of print]. doi: 10.1016/j.clinre.2012.03035).
10. Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001; 98:2720-2755.
11. Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, et al. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol 2006; 101: 2537-2545. (Pubitemid 44665250)
12. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology 2005; 42:1437-1445.
13. Pan JJ, Yang CF, Chu CJ, Chang FY, Lee SD. Prediction of liver fibrosis in patients with chronic hepatitis B by serum markers. Hepatogastroenterology 2007; 54:1503-1506.
14. Schmilovitz-Weiss H, Tovar A, Halpern M, Sulkes J, Braun M, Rotman Y, et al. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection. J Viral Hepat 2006; 13:671-677. (Pubitemid 44401195)
15. Wai C-T, Cheng CL,Wee A, Dan Y-Y, Chan E, Chua W, et al. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int 2006; 26:666-672. (Pubitemid 43983883)
16. Liu WP, Xu DJ, Zhao LR, Lu ZH,Wang YH, Lang ZW, et al. The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B. Zhonghua Nei Ke Za Zhi 2008; 47:308-312.
17. Vardar R, Gunsar F, Sertoz R, Ozacar T, Nart D, Barbet FY, et al. The relationship between HBV-DNA level and histology in patients with naïve chronic HBV infection. Hepatogastroenterology 2010; 57:908-912.
18. Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int 2007; 27:969-976. (Pubitemid 47261951)
19. Chen YP, Hou JL, Dai L,Wang JL, Zhu YF. Ultrasonic scores combined with blood indexes for screening and predicting compensated liver cirrhosis in chronic hepatitis B patients. Nan Fang Yi Ke Da Xue Xue Bao 2008; 28:2157-2160.
20. Zhou K, Gao CF, Zhao YP, Liu HL, Zheng RD, Xian JC, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 2010; 25:1569-1577.
21. Hui A, Chan HL,Wong VW, Liew CT, Chim AM, Chan FK, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005; 100:616-623. (Pubitemid 40487561)
22. Prytz H, Bjorneboe M, Christoffersen P, Poulsen H, Orskov F. Correlation between hepatic morphology and immunoglobulins and antibodies to Escherichia coli in cirrhosis. Gut 1977; 18:28-32. (Pubitemid 8107248)
23. Shen H, Zhang M, Kaita K, Minuk GY, Rempel J, Gong Y. Expression of Fc fragment receptors of immunoglobulin G (Fc gammaRs) in rat hepatic stellate cells. Dig Dis Sci 2005; 50:181-187. (Pubitemid 40379160)
24. Imperial JC. Natural history of chronic hepatitis B and C. J Gastroenterol Hepatol 1999; 14 (Suppl 5):S1-S5. (Pubitemid 29281857)
25. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003; 38:257-265. (Pubitemid 36286537)
26. Giannini E, Ceppa P, Botta F, Fasoli A, Romagnoli P, Cresta E, et al. Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients. Liver 1999; 19:432-437. (Pubitemid 29457223)
27. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003; 39:222-230. (Pubitemid 36920558)
28. Aster R. Pooling of platelets in the spleen: role in the pathogenesis 'hypersplenic' thrombocytopenia. J Clin Invest 1996; 45:645-657.
29. Kawasaki T, Takeshita A, Souda K, Kobayashi Y, Kikuyama M, Suzuki F, et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol 1999; 94:1918-1922. (Pubitemid 29315911)
30. Kondo R, Yano H, Nakashima O, Tanikawa K, Nomura Y, Kage M. Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C. J Gastroenterol 2012 [Epub ahead of print].
31. Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003; 163:218-224. (Pubitemid 36120190)
32. Chu CM, Karayiannis P, Fowler MJ, Monjardino J, Liaw YF, Thomas HC. Natural history of hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 1985; 5:431-434. (Pubitemid 15065950)
33. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, et al. Chronic hepatitis in HBsAg carriers with serum HBV DNA and anti-HBe. Gastroenterology 1986; 90:1268-1273. (Pubitemid 16145494)
34. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23:1334-1340. (Pubitemid 26181213)
35. Kamimoto Y, Horiuchi S, Tanase S, Morino Y. Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology 1985; 5:367-375. (Pubitemid 15065940)
36. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122:366-375. (Pubitemid 34116988)
37. Nalpas B, Vassault A, Le Guillou A. Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology 1984; 4:893-896. (Pubitemid 14007661)
38. Yuen MF, Ng IO, Fan ST, Yuan HJ,Wong DK, Yuen DJ, et al. Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients with chronic hepatitis B. Am J Gastroenterol 2004; 99:2032-2037. (Pubitemid 39421251)
39. Kim JD, Choi JY, Bae SH, Yang JM, Han NI, Choi SW, et al. Hepatitis B virus load in serum does not reflect histologic activity in patients with decompensated cirrhosis. Clin Gastroenterol Hepatol 2010; 8:60-65.
40. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011; 17:47-58.